Joshua T. Brumm - Oct 1, 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Chief Executive Officer and President, Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/4/2021, 05:03 PM
Previous filing
Sep 22, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Gift $0 -3.5K -3.53% $0.00 95.5K Oct 1, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a charitable donation to a third party effective October 1, 2021 in which no value was received in return.
F2 Includes 80,270 unvested RSUs.

Remarks:

Chief Executive Officer and President